Day One Biopharmaceuticals Ownership 2024 | Who Owns Day One Biopharmaceuticals Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

28.18%

Insider Ownership

19.71%

Retail Ownership

52.11%

Institutional Holders

55.00

Day One Biopharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.9.79%0.19%7,809,852--129,018,755Mar 31, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC8.06%9.80%6,430,257-1,178,137-15.48%106,227,846Mar 31, 2024
BLACKROCK INC.6.31%0.00%5,031,435-94,636-1.85%83,119,306Mar 31, 2024
VANGUARD GROUP INC5.99%0.00%4,774,4834,7370.10%78,874,459Mar 31, 2024
FMR LLC5.52%0.00%4,404,341436,17510.99%72,759,721Mar 31, 2024
FRANKLIN RESOURCES INC4.77%0.02%3,806,790-430,005-10.15%62,888,164Mar 31, 2024
STATE STREET CORP3.63%0.00%2,894,883-485,215-14.36%47,823,467Mar 31, 2024
VIKING GLOBAL INVESTORS LP3.21%0.16%2,558,563--42,267,461Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.98%0.04%2,375,137-196,431-7.64%39,237,263Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.88%0.00%2,299,764-17,000-0.73%37,993,000Mar 31, 2024
BRAIDWELL LP2.72%1.16%2,173,704-2,041,869-48.44%35,909,590Mar 31, 2024
GOLDMAN SACHS GROUP INC2.68%0.01%2,137,49118,6420.88%35,311,351Mar 31, 2024
JANUS HENDERSON GROUP PLC2.55%0.02%2,032,384336,28119.83%33,574,983Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.21%0.51%1,765,3124,1340.23%29,162,954Mar 31, 2024
TIMESSQUARE CAPITAL MANAGEMENT, LLC2.05%0.39%1,635,145-30,920-1.86%27,013,000Mar 31, 2024
ESTUARY CAPITAL MANAGEMENT LP2.02%10.81%1,611,137728,24082.48%26,615,983Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.73%0.00%1,376,96128,1422.09%22,750,646Mar 31, 2024
FIRST TURN MANAGEMENT, LLC1.65%3.26%1,318,207-382,742-22.50%21,776,780Mar 31, 2024
MAVERICK CAPITAL LTD1.58%0.39%1,256,5701,256,570100.00%20,758,536Mar 31, 2024
BOXER CAPITAL, LLC1.49%0.97%1,189,943--19,657,858Mar 31, 2024

Day One Biopharmaceuticals's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 9.79% of the company's total share outstanding, currently valued at $129.02M. The top 10 institutional shareholders own together 53.13% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ESTUARY CAPITAL MANAGEMENT LP2.02%10.81%1,611,137728,24082.48%26,615,983Mar 31, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC8.06%9.80%6,430,257-1,178,137-15.48%106,227,846Mar 31, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.44%3.82%349,679-29,947-7.89%5,776,697Mar 31, 2024
FIRST TURN MANAGEMENT, LLC1.65%3.26%1,318,207-382,742-22.50%21,776,780Mar 31, 2024
PROPEL BIO MANAGEMENT, LLC0.34%2.60%270,664--4,471,369Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC0.84%2.51%666,463-20,000-2.91%11,009,969Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.87%1.40%691,81266,06310.56%11,428,734Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.25%1.38%195,497195,497100.00%3,229,610Mar 31, 2024
BRAIDWELL LP2.72%1.16%2,173,704-2,041,869-48.44%35,909,590Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.0.62%1.14%492,627-20,373-3.97%8,138,198Mar 31, 2024
BOXER CAPITAL, LLC1.49%0.97%1,189,943--19,657,858Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.45%0.61%361,76758,44919.27%5,976,391Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2.21%0.51%1,765,3124,1340.23%29,162,954Mar 31, 2024
SAMSARA BIOCAPITAL, LLC0.25%0.50%196,425--3,244,941Mar 31, 2024
TIMESSQUARE CAPITAL MANAGEMENT, LLC2.05%0.39%1,635,145-30,920-1.86%27,013,000Mar 31, 2024
MAVERICK CAPITAL LTD1.58%0.39%1,256,5701,256,570100.00%20,758,536Mar 31, 2024
PFM HEALTH SCIENCES, LP0.45%0.28%355,251-948,324-72.75%5,868,747Mar 31, 2024
SUMMIT ROCK ADVISORS, LP0.06%0.27%51,50251,502100.00%850,813Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.9.79%0.19%7,809,852--129,018,755Mar 31, 2024
DIAMETRIC CAPITAL, LP0.02%0.17%18,79618,796100.00%310,509Mar 31, 2024

The largest Day One Biopharmaceuticals shareholder by % of total assets is ESTUARY CAPITAL MANAGEMENT LP. The company owns 1.61M shares of Day One Biopharmaceuticals (DAWN), representing 10.81% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAVERICK CAPITAL LTD1.58%0.39%1,256,5701,256,570100.00%20,758,536Mar 31, 2024
ESTUARY CAPITAL MANAGEMENT LP2.02%10.81%1,611,137728,24082.48%26,615,983Mar 31, 2024
FMR LLC5.52%0.00%4,404,341436,17510.99%72,759,721Mar 31, 2024
JANUS HENDERSON GROUP PLC2.55%0.02%2,032,384336,28119.83%33,574,983Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC0.90%0.12%719,011235,77248.79%11,878,062Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP1.23%0.00%981,572203,65526.18%16,215,570Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.25%1.38%195,497195,497100.00%3,229,610Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.21%0.00%169,522169,522100.00%2,800,503Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.09%0.00%74,15474,154100.00%1,225,024Mar 31, 2024
CITIGROUP INC0.21%0.00%171,05071,12571.18%2,825,746Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.87%1.40%691,81266,06310.56%11,428,734Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.34%0.00%272,11763,14830.22%4,495,373Mar 31, 2024
J. GOLDMAN & CO LP0.08%0.03%61,32761,327100.00%1,013,122Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.30%0.03%237,74858,81432.87%3,927,596Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.45%0.61%361,76758,44919.27%5,976,391Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.12%0.01%97,62156,718138.66%1,613,000Mar 31, 2024
SUMMIT ROCK ADVISORS, LP0.06%0.27%51,50251,502100.00%850,813Mar 31, 2024
CITADEL ADVISORS LLC0.06%0.00%47,26539,998550.41%780,817Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.07%0.00%53,15237,547240.61%878,071Mar 31, 2024
UBS GROUP AG0.21%0.00%164,01837,37829.52%2,709,577Mar 31, 2024

As of Mar 31 2024, Day One Biopharmaceuticals's largest institutional buyer is MAVERICK CAPITAL LTD. The company purchased 1.26M stocks of DAWN, valued at $20.76M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BRAIDWELL LP2.72%1.16%2,173,704-2,041,869-48.44%35,909,590Mar 31, 2024
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC8.06%9.80%6,430,257-1,178,137-15.48%106,227,846Mar 31, 2024
BAKER BROS. ADVISORS LP----1,000,000-100.00%-Mar 31, 2024
PFM HEALTH SCIENCES, LP0.45%0.28%355,251-948,324-72.75%5,868,747Mar 31, 2024
STATE STREET CORP3.63%0.00%2,894,883-485,215-14.36%47,823,467Mar 31, 2024
FRANKLIN RESOURCES INC4.77%0.02%3,806,790-430,005-10.15%62,888,164Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.----390,167-100.00%-Mar 31, 2024
FIRST TURN MANAGEMENT, LLC1.65%3.26%1,318,207-382,742-22.50%21,776,780Mar 31, 2024
PIER CAPITAL, LLC----258,685-100.00%-Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC1.49%0.10%1,185,000-200,000-14.44%19,576,200Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.98%0.04%2,375,137-196,431-7.64%39,237,263Mar 31, 2024
BARCLAYS PLC0.08%0.00%67,466-118,373-63.70%1,114,000Mar 31, 2024
MORGAN STANLEY0.29%0.00%232,550-101,889-30.47%3,841,726Mar 31, 2024
BLACKROCK INC.6.31%0.00%5,031,435-94,636-1.85%83,119,306Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----88,000-100.00%-Mar 31, 2024
HRT FINANCIAL LP----73,887-100.00%-Mar 31, 2024
SG AMERICAS SECURITIES, LLC----64,692-100.00%-Mar 31, 2024
TD ASSET MANAGEMENT INC0.01%0.00%10,796-44,400-80.44%178,350Mar 31, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.24%0.01%193,224-43,123-18.25%3,192,060Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----42,500-100.00%-Mar 31, 2024

As of Mar 31 2024, Day One Biopharmaceuticals's biggest institutional seller is BRAIDWELL LP. The company sold -2.04M shares of DAWN, valued at $35.91M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAVERICK CAPITAL LTD1.58%0.39%1,256,5701,256,570100.00%20,758,536Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.25%1.38%195,497195,497100.00%3,229,610Mar 31, 2024
PRUDENTIAL FINANCIAL INC0.21%0.00%169,522169,522100.00%2,800,503Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.09%0.00%74,15474,154100.00%1,225,024Mar 31, 2024
J. GOLDMAN & CO LP0.08%0.03%61,32761,327100.00%1,013,122Mar 31, 2024
SUMMIT ROCK ADVISORS, LP0.06%0.27%51,50251,502100.00%850,813Mar 31, 2024
BANK OF AMERICA CORP /DE/0.04%0.00%32,40032,400100.00%535,248,000Mar 31, 2024
JUMP FINANCIAL, LLC0.04%0.01%32,14232,142100.00%530,986Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%0.00%30,90030,900100.00%510,468Mar 31, 2024
XTX TOPCO LTD0.03%0.05%24,04224,042100.00%397,174Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.03%0.00%20,41220,412100.00%337,206Mar 31, 2024
NEBULA RESEARCH & DEVELOPMENT LLC0.02%0.07%19,41919,419100.00%320,802Mar 31, 2024
DIAMETRIC CAPITAL, LP0.02%0.17%18,79618,796100.00%310,509Mar 31, 2024
PANAGORA ASSET MANAGEMENT INC0.02%0.00%18,56018,560100.00%306,611Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%0.00%13,93513,935100.00%230,000Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.02%0.02%13,37413,374100.00%220,938Mar 31, 2024
BANK OF AMERICA CORP /DE/0.01%-10,00010,000100.00%165,200,000Mar 31, 2024
TSFG, LLC0.00%0.01%3,0003,000100.00%50,000Mar 31, 2024
0.00%0.00%2,8242,824100.00%46,652Mar 31, 2024
SIMPLEX TRADING, LLC0.00%-2,7582,758100.00%45,000Mar 31, 2024
CONTINUUM ADVISORY, LLC0.00%0.00%1,3401,340100.00%21,949,000Mar 31, 2024
PACER ADVISORS, INC.0.00%-902902100.00%14,901Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.00%0.01%582582100.00%9,615Mar 31, 2024
ICA GROUP WEALTH MANAGEMENT, LLC-0.00%3535100.00%578Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1212100.00%198Mar 31, 2024

Day One Biopharmaceuticals's largest new institutional shareholder by number of shares is MAVERICK CAPITAL LTD, purchased 1.26M shares, valued at $20.76M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP----1,000,000-100.00%-Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.----390,167-100.00%-Mar 31, 2024
PIER CAPITAL, LLC----258,685-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----88,000-100.00%-Mar 31, 2024
HRT FINANCIAL LP----73,887-100.00%-Mar 31, 2024
SG AMERICAS SECURITIES, LLC----64,692-100.00%-Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----42,500-100.00%-Mar 31, 2024
JUPITER ASSET MANAGEMENT LTD----36,671-100.00%-Mar 31, 2024
GSA CAPITAL PARTNERS LLP----30,378-100.00%-Mar 31, 2024
SQUAREPOINT OPS LLC----15,927-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----15,500-100.00%-Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----14,395-100.00%-Mar 31, 2024
E FUND MANAGEMENT CO., LTD.----12,618-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----10,651-100.00%-Mar 31, 2024
SANDIA INVESTMENT MANAGEMENT LP----5,980-100.00%-Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.----61-100.00%-Mar 31, 2024

Day One Biopharmaceuticals's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -1.00M shares, valued at -, as of undefined.

Day One Biopharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AMG FUNDS1.22%135,900--Jan 31, 2024
Tema ETF Trust0.92%40,95828,418226.62%Feb 29, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.18%22,400--Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS IV0.10%110,000--Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.08%41,661--Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.08%1,259,447-4,026-0.32%Dec 31, 2023
BlackRock Health Sciences Trust II0.07%200,635--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.07%255,035--Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.06%275,886-5,739-2.04%Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.05%406,669--Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.04%1,013,393-54,551-5.11%Feb 29, 2024
FIDELITY CAPITAL TRUST0.03%287,384--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%9,6314474.87%Dec 31, 2023
LORD ABBETT SECURITIES TRUST0.02%93,175--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%114,6007,2386.74%Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%46,5027441.63%Feb 29, 2024
VANGUARD INDEX FUNDS0.01%4,977,596974,69624.35%Dec 31, 2023
FIDELITY SECURITIES FUND0.01%901,833--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%607,633159,90035.71%Feb 29, 2024
T. Rowe Price Equity Series, Inc.0.01%14,130--Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.01%58,4221,9033.37%Dec 29, 2023
ALPS ETF Trust0.01%64,4393,0084.90%Feb 29, 2024
ETFis Series Trust I0.00%5,754-1,585-21.60%Jan 31, 2024
Nushares ETF Trust0.00%28,524--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%731--Dec 31, 2023
ProFunds0.00%26,04012,26589.04%Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%553,158-702-0.13%Feb 29, 2024
Calvert Variable Products, Inc.0.00%6,279--Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%290,96910,0473.58%Feb 29, 2024
Direxion Shares ETF Trust0.00%226,92940,80821.93%Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%40,860--Dec 31, 2023
JANUS INVESTMENT FUND0.00%400,350--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%16,078--Feb 29, 2024
FIDELITY ADVISOR SERIES I0.00%158,900--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%25,4862981.18%Dec 31, 2023
Principal Exchange-Traded Funds0.00%9,741-800-7.59%Mar 31, 2024
Brinker Capital Destinations Trust0.00%48,037-8,571-15.14%Feb 29, 2024
RBB FUND, INC.0.00%73,52840,755124.36%Feb 29, 2024
Dimensional ETF Trust0.00%321,20553,02019.77%Jan 31, 2024
ETF Series Solutions0.00%11,8491,89819.07%Feb 29, 2024
VANGUARD WORLD FUND0.00%162,52414,87110.07%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,961-340-10.30%Dec 31, 2023
BlackRock ETF Trust0.00%404--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%376,387242,729181.60%Jan 31, 2024
Dunham Funds0.00%24,99624,996-Jan 31, 2024
Fidelity Rutland Square Trust II0.00%337,665-30,240-8.22%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%722-5,656-88.68%Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%997-1,283-56.27%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%21,400--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,950-358-10.82%Dec 31, 2023
EQ ADVISORS TRUST0.00%170,26215,3629.92%Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%287,07535,55214.13%Feb 29, 2024
RYDEX SERIES FUNDS0.00%569--Dec 31, 2023
Trust for Advised Portfolios0.00%2,567--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%17,3439,917133.54%Dec 31, 2023
VALIC Co I0.00%24,044-97-0.40%Feb 29, 2024
PENN SERIES FUNDS INC0.00%2,300--Dec 29, 2023
NATIONWIDE MUTUAL FUNDS0.00%9,523-352-3.56%Jan 31, 2024
RYDEX DYNAMIC FUNDS0.00%282--Dec 31, 2023
SA FUNDS INVESTMENT TRUST0.00%977--Dec 31, 2023
PROSHARES TRUST0.00%15,6842,04014.95%Feb 29, 2024
SPDR SERIES TRUST0.00%2,108,949206,25310.84%Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%6,270--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%4,108--Dec 31, 2023
HC CAPITAL TRUST0.00%1,214-77-5.96%Dec 31, 2023
NORTHERN FUNDS0.00%34,057-1,040-2.96%Dec 29, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%81,9702,2002.76%Dec 31, 2023
RYDEX VARIABLE TRUST0.00%37--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%95,000--Dec 31, 2023
Pacer Funds Trust0.00%1,292-894-40.90%Jan 31, 2024
Brighthouse Funds Trust II0.00%57,643--Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%10,372--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%2,325--Feb 29, 2024
TRANSAMERICA SERIES TRUST0.00%20,533--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%7,098-29-0.41%Jan 31, 2024
Guggenheim Active Allocation Fund0.00%122--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%36,628-538-1.45%Dec 31, 2023
Advisors' Inner Circle Fund III0.00%178-72,221-99.75%Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%11,974--Dec 31, 2023
EMPOWER FUNDS, INC.0.00%12,327--Dec 31, 2023
Invesco Exchange-Traded Fund Trust II0.00%2,32880452.76%Feb 29, 2024
PACIFIC SELECT FUND0.00%21,0242571.24%Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%14,368--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%4,857--Dec 31, 2023
iSHARES TRUST0.00%58,051-2,834,500-97.99%Feb 29, 2024
Bridge Builder Trust0.00%12,6344703.86%Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%7,776--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%17,3601,66010.57%Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%242--Dec 31, 2023
John Hancock Funds II0.00%6,468-7,842-54.80%Feb 29, 2024

Day One Biopharmaceuticals's largest mutual fund holder by % of total assets is "AMG FUNDS", owning 135.90K shares, compromising 1.22% of its total assets.

Day One Biopharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2455-59.26%
31 Dec, 231358.00%
30 Sep, 23125-9.42%
30 Jun, 2313813.11%
31 Mar, 2312214.02%
31 Dec, 2210720.22%
30 Sep, 2289-
30 Jun, 228936.92%
31 Mar, 226514.04%
31 Dec, 215726.67%
30 Sep, 214540.63%
30 Jun, 2132-

As of 31 Mar 24, 55 institutions are holding Day One Biopharmaceuticals's shares, representing a decrease of -59.26% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2422,478,030-70.60%
31 Dec, 2376,449,174-1.06%
30 Sep, 2377,271,031-1.69%
30 Jun, 2378,597,05529.09%
31 Mar, 2360,886,1961.12%
31 Dec, 2260,213,794-0.83%
30 Sep, 2260,715,4342.25%
30 Jun, 2259,382,17337.19%
31 Mar, 2243,283,8804.36%
31 Dec, 2141,477,324117.20%
30 Sep, 2119,096,0407.74%
30 Jun, 2117,724,839-

Day One Biopharmaceuticals (DAWN) has 22.48M shares outstanding as of 31 Mar 24, down -70.60% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2428.18%0.36%
31 Dec, 2388.94%0.84%
30 Sep, 23103.08%0.86%
30 Jun, 23109.20%1.53%
31 Mar, 2384.60%1.00%
31 Dec, 2291.98%1.26%
30 Sep, 2285.50%0.90%
30 Jun, 2297.73%1.78%
31 Mar, 2274.14%0.59%
31 Dec, 21112.22%4.20%
30 Sep, 2151.67%0.84%
30 Jun, 2178.21%-

As of 31 Mar 24, Day One Biopharmaceuticals is held by 28.18% institutional shareholders, representing a 0.36% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2426-65.33%
31 Dec, 237511.94%
30 Sep, 2367-31.63%
30 Jun, 239846.27%
31 Mar, 23676.35%
31 Dec, 226312.50%
30 Sep, 2256-9.68%
30 Jun, 226263.16%
31 Mar, 2238-9.52%
31 Dec, 214231.25%
30 Sep, 2132-
30 Jun, 2132-

26 institutional shareholders have increased their position in DAWN stock as of 31 Mar 24 compared to 75 in the previous quarter (a -65.33% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2418-45.45%
31 Dec, 2333-
30 Sep, 233350.00%
30 Jun, 2322-24.14%
31 Mar, 232926.09%
31 Dec, 222327.78%
30 Sep, 221820.00%
30 Jun, 221525.00%
31 Mar, 2212140.00%
31 Dec, 215-28.57%
30 Sep, 217-
30 Jun, 21--

18 institutional shareholders have reduced their position in DAWN stock as of 31 Mar 24 compared to 33 in the previous quarter (a -45.45% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2455-59.26%22,478,030-70.60%28.18%0.36%26-65.33%18-45.45%
31 Dec, 231358.00%76,449,174-1.06%88.94%0.84%7511.94%33-
30 Sep, 23125-9.42%77,271,031-1.69%103.08%0.86%67-31.63%3350.00%
30 Jun, 2313813.11%78,597,05529.09%109.20%1.53%9846.27%22-24.14%
31 Mar, 2312214.02%60,886,1961.12%84.60%1.00%676.35%2926.09%
31 Dec, 2210720.22%60,213,794-0.83%91.98%1.26%6312.50%2327.78%
30 Sep, 2289-60,715,4342.25%85.50%0.90%56-9.68%1820.00%
30 Jun, 228936.92%59,382,17337.19%97.73%1.78%6263.16%1525.00%
31 Mar, 226514.04%43,283,8804.36%74.14%0.59%38-9.52%12140.00%
31 Dec, 215726.67%41,477,324117.20%112.22%4.20%4231.25%5-28.57%
30 Sep, 214540.63%19,096,0407.74%51.67%0.84%32-7-
30 Jun, 2132-17,724,839-78.21%-32---

Day One Biopharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell7,873$16.08$126.59K654,728
May 17, 2024Blackman Samuel C.officer HEAD OF R&DS-SaleSell2,267$16.08$36.45K1,171,081
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYS-SaleSell2,675$16.08$43.01K224,868

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell7,873$16.08$126.59K654,728
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell11,687--163,626
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell4,750--47,500
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell3,562--21,380
May 17, 2024Blackman Samuel C.officer HEAD OF R&DS-SaleSell2,267$16.08$36.45K1,171,081
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell6,062--84,876
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell1,437--14,378
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell1,187--7,130
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYS-SaleSell2,675$16.08$43.01K224,868
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptSell6,625--92,750
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptSell2,250--22,500

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptBuy11,687--662,601
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERS-SaleSell7,873$16.08$126.59K654,728
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptBuy4,750--650,914
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptBuy3,562--646,164
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell11,687--163,626
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell4,750--47,500
May 17, 2024Bender Jeremydirector, officer CHIEF EXECUTIVE OFFICERM-ExemptSell3,562--21,380
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptBuy6,062--1,173,348
May 17, 2024Blackman Samuel C.officer HEAD OF R&DS-SaleSell2,267$16.08$36.45K1,171,081
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptBuy1,437--1,167,286
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptBuy1,187--1,165,849
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell6,062--84,876
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell1,437--14,378
May 17, 2024Blackman Samuel C.officer HEAD OF R&DM-ExemptSell1,187--7,130
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptBuy6,625--227,543
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYS-SaleSell2,675$16.08$43.01K224,868
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptBuy2,250--220,918
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptBuy1,375--218,668
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptSell6,625--92,750
May 17, 2024York Charles N IIofficer COO, CFO AND SECRETARYM-ExemptSell2,250--22,500

The last insider sell of Day One Biopharmaceuticals's stock was made by Bender Jeremy on May 17 2024, selling 7,873 shares at $16.08 per share (valued at $126.59K).

Day One Biopharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024122450.00%
Q1 20242219115.79%
Q4 2023111668.75%
Q3 2023101471.43%
Q2 20231410140.00%
Q1 2023122254.55%
Q4 202232910.34%
Q3 20223624.84%
Q2 20221611600.00%
Q1 202292450.00%
Q4 202121216.67%
Q3 202111100.00%
Q2 2021173154.84%
Q1 20212--

12 total buy trades, and 24 total sell trades (buy/sell ratio of 0.50%) were made by Day One Biopharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-12-
Q1 2024-7-
Q4 20233475.00%
Q3 2023-3-
Q2 20231425.00%
Q1 2023-16-
Q4 2022-25-
Q3 2022-55-
Q2 202251500.00%
Q1 202232150.00%
Q4 2021-8-
Q3 2021---
Q2 20216--
Q1 20211--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 12 open market sell trades of Day One Biopharmaceuticals's stocks.

Day One Biopharmaceuticals Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
MREOMereo BioPharma Group plc
ELDNEledon Pharmaceuticals, Inc.
XFORX4 Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
PDSBPDS Biotechnology Corporation
HOOKHOOKIPA Pharma Inc.

DAWN Ownership FAQ


Day One Biopharmaceuticals is owned by institutional shareholders (28.18%), insiders (19.71%), and public (52.11%). The largest institutional shareholder of Day One Biopharmaceuticals is RA CAPITAL MANAGEMENT, L.P. (9.79% of total shares) and the top mutual fund owner is AMG FUNDS (1.22% of total shares).

Day One Biopharmaceuticals's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, BLACKROCK INC., VANGUARD GROUP INC, and FMR LLC. The top five shareholders own together 35.66% of the company's share outstanding.

As of Mar 2024, there are 55 institutional shareholders of Day One Biopharmaceuticals.

RA CAPITAL MANAGEMENT, L.P owns 7.81M shares of Day One Biopharmaceuticals, representing 9.79% of the company's total shares outstanding, valued at $129.02M (as of Mar 2024).

As of Mar 2024, ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds 6.43M shares of Day One Biopharmaceuticals (DAWN), compromising 8.06% of the company, valued at $106.23M.

BLACKROCK INC is the third largest holder of Day One Biopharmaceuticals. The company owns 5.03M of the company's shares outstanding (worth $83.12M).